On October 1, the DC Circuit stayed its own September 25 ruling pending appeal, extending the litigation after the court upheld the Pentagon's exclusion of Anthropic 2-1 under §4713 on grounds that Claude's safety restrictions created operational uncertainty.
Anthropic said it is "considering all options, including further review". A publication also reported Anthropic's valuation grew from roughly $500 billion to roughly $2 trillion despite the designation, and one newsletter argued the government's three grounds are each without merit, calling built-in refusals required by White House testing policy.